Tricuspid regurgitation laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Tricuspid regurgitation}} | {{Tricuspid regurgitation}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
There are no diagnostic laboratory findings associated with [[tricuspid regurgitation]]. | There are no diagnostic laboratory findings associated with [[tricuspid regurgitation]]. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
There are no diagnostic laboratory findings associated with [[tricuspid regurgitation]]. | * There are no diagnostic laboratory findings associated with [[tricuspid regurgitation]]. | ||
* [[Biomarkers]] can predict the [[cardiovascular]] complications in [[pregnancy]] and the following can be used to elevate:<ref name="pmid20883932">{{cite journal| author=Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD | display-authors=etal| title=B-type natriuretic peptide in pregnant women with heart disease. | journal=J Am Coll Cardiol | year= 2010 | volume= 56 | issue= 15 | pages= 1247-53 | pmid=20883932 | doi=10.1016/j.jacc.2010.02.076 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20883932 }}</ref><ref name="pmid243347172">{{cite journal| author=Kampman MA, Balci A, van Veldhuisen DJ, van Dijk AP, Roos-Hesselink JW, Sollie-Szarynska KM | display-authors=etal| title=N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. | journal=Eur Heart J | year= 2014 | volume= 35 | issue= 11 | pages= 708-15 | pmid=24334717 | doi=10.1093/eurheartj/eht526 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24334717 }}</ref> | |||
** N-terminal pro-B-type [[Natriuretic peptides|natriuretic peptide]] | |||
** B-type [[Natriuretic peptides|natriuretic peptide]] | |||
==References== | ==References== | ||
| Line 53: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category: Cardiology]] | ||
Latest revision as of 15:48, 6 May 2020
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation laboratory findings |
|
Risk calculators and risk factors for Tricuspid regurgitation laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There are no diagnostic laboratory findings associated with tricuspid regurgitation.
Laboratory Findings
- There are no diagnostic laboratory findings associated with tricuspid regurgitation.
- Biomarkers can predict the cardiovascular complications in pregnancy and the following can be used to elevate:[1][2]
- N-terminal pro-B-type natriuretic peptide
- B-type natriuretic peptide
References
- ↑ Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD; et al. (2010). "B-type natriuretic peptide in pregnant women with heart disease". J Am Coll Cardiol. 56 (15): 1247–53. doi:10.1016/j.jacc.2010.02.076. PMID 20883932.
- ↑ Kampman MA, Balci A, van Veldhuisen DJ, van Dijk AP, Roos-Hesselink JW, Sollie-Szarynska KM; et al. (2014). "N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease". Eur Heart J. 35 (11): 708–15. doi:10.1093/eurheartj/eht526. PMID 24334717.